Pub Date : 2025-12-18DOI: 10.1007/s10728-025-00553-y
Sonu Goel, Chirag Goel, Diksha Walia, Leimapokpam Swasticharan, Prakash Chandra Gupta, Sitanshu Sekhar Kar
Tobacco use remains a critical global public health challenge, representing the leading preventable cause of morbidity and mortality worldwide. The World Health Organisation's Framework Convention on Tobacco Control, ratified by 183 parties, includes Articles 9 and 10, which regulate the contents and emissions of tobacco products. Like many other WHO-FCTC articles, the implementation of these provisions faces significant challenges. These hurdles include tobacco industry interference, the proliferation of novel tobacco and nicotine products, the complexity of regulating product attractiveness, addictiveness, and toxicity, inadequate testing infrastructure, legal and political barriers, and coordination challenges among the regulatory authorities of different countries. Overcoming these impediments is crucial, as robust enforcement of Articles 9 and 10 holds the potential to reduce the substantial global burden of over 7 million annual deaths attributable to tobacco use. Effective implementation will require integrating these articles into domestic tobacco control legislation, establishing well-equipped testing facilities, fostering multi-sectoral coordination, and bolstering international research collaborations and capacity-building efforts. By surmounting these challenges, countries can harness the full power of the WHO-FCTC to curb the tobacco epidemic.
{"title":"Strengthening Tobacco Product Regulation: Addressing Challenges and Strategies for Articles 9 and 10 Implementation.","authors":"Sonu Goel, Chirag Goel, Diksha Walia, Leimapokpam Swasticharan, Prakash Chandra Gupta, Sitanshu Sekhar Kar","doi":"10.1007/s10728-025-00553-y","DOIUrl":"https://doi.org/10.1007/s10728-025-00553-y","url":null,"abstract":"<p><p>Tobacco use remains a critical global public health challenge, representing the leading preventable cause of morbidity and mortality worldwide. The World Health Organisation's Framework Convention on Tobacco Control, ratified by 183 parties, includes Articles 9 and 10, which regulate the contents and emissions of tobacco products. Like many other WHO-FCTC articles, the implementation of these provisions faces significant challenges. These hurdles include tobacco industry interference, the proliferation of novel tobacco and nicotine products, the complexity of regulating product attractiveness, addictiveness, and toxicity, inadequate testing infrastructure, legal and political barriers, and coordination challenges among the regulatory authorities of different countries. Overcoming these impediments is crucial, as robust enforcement of Articles 9 and 10 holds the potential to reduce the substantial global burden of over 7 million annual deaths attributable to tobacco use. Effective implementation will require integrating these articles into domestic tobacco control legislation, establishing well-equipped testing facilities, fostering multi-sectoral coordination, and bolstering international research collaborations and capacity-building efforts. By surmounting these challenges, countries can harness the full power of the WHO-FCTC to curb the tobacco epidemic.</p>","PeriodicalId":46740,"journal":{"name":"Health Care Analysis","volume":" ","pages":""},"PeriodicalIF":1.6,"publicationDate":"2025-12-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145776160","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"哲学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-12-06DOI: 10.1007/s10728-025-00552-z
Anders Herlitz, Erik Malmqvist, Christian Munthe
Sustainable access to effective antibiotics is a main rationale for addressing antimicrobial resistance, for calls to enhance antibiotic supply security and for development support to promote health system capacity in low- and middle-income settings. Standard models for valuing pharmaceuticals fail to capture the full value of sustainable access to effective antibiotics. In effect, assessments of societal or corporate investments to promote such access underestimate their value and the cost of foregoing them. In effect, measures that could address existing sustainability problems in antibiotic supply systems are hampered. We review the features needed to avoid these problems and assess suggestions to address the flaws of existing approaches, such as the STEDI-model. On this basis, we propose the 3D Value Framework, a straightforward and comprehensive model that focusses directly on what types of valuable outcomes there can be related to having sustainable access to effective antibiotics. We also sketch how this model can be used in cost-effectiveness analysis grounding public decision-making and discuss further applications in other settings.
{"title":"The 3D Value Framework for Sustainable Access to Effective Antibiotics.","authors":"Anders Herlitz, Erik Malmqvist, Christian Munthe","doi":"10.1007/s10728-025-00552-z","DOIUrl":"10.1007/s10728-025-00552-z","url":null,"abstract":"<p><p>Sustainable access to effective antibiotics is a main rationale for addressing antimicrobial resistance, for calls to enhance antibiotic supply security and for development support to promote health system capacity in low- and middle-income settings. Standard models for valuing pharmaceuticals fail to capture the full value of sustainable access to effective antibiotics. In effect, assessments of societal or corporate investments to promote such access underestimate their value and the cost of foregoing them. In effect, measures that could address existing sustainability problems in antibiotic supply systems are hampered. We review the features needed to avoid these problems and assess suggestions to address the flaws of existing approaches, such as the STEDI-model. On this basis, we propose the 3D Value Framework, a straightforward and comprehensive model that focusses directly on what types of valuable outcomes there can be related to having sustainable access to effective antibiotics. We also sketch how this model can be used in cost-effectiveness analysis grounding public decision-making and discuss further applications in other settings.</p>","PeriodicalId":46740,"journal":{"name":"Health Care Analysis","volume":" ","pages":""},"PeriodicalIF":1.6,"publicationDate":"2025-12-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145688388","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"哲学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-12-01Epub Date: 2024-12-31DOI: 10.1007/s10728-024-00507-w
Alper Aytekin, Rukiye Ayaz, Ahmet Ayaz
This study employs bibliometric and thematic analysis to evaluate the growing body of research on subjective well-being and quality of life during the COVID-19 pandemic. The findings underscore the pandemic's profound impacts on global health, evidenced by a notable increase in studies addressing mental health and quality of life, fostered by international scientific collaboration. Keyword analysis reveals critical themes, including the pandemic's influence on mental health, physical activity, and social support systems. This research provides valuable insights into the long-term consequences of the pandemic and highlights adaptive strategies for managing future crises. By identifying key trends and research gaps, the study serves as an essential resource for academics, policymakers, and public health practitioners, offering a roadmap for future investigations.
{"title":"Impact of the COVID-19 Pandemic on Subjective Well-Being and Quality of Life: A Comprehensive Bibliometric and Thematic Analysis.","authors":"Alper Aytekin, Rukiye Ayaz, Ahmet Ayaz","doi":"10.1007/s10728-024-00507-w","DOIUrl":"10.1007/s10728-024-00507-w","url":null,"abstract":"<p><p>This study employs bibliometric and thematic analysis to evaluate the growing body of research on subjective well-being and quality of life during the COVID-19 pandemic. The findings underscore the pandemic's profound impacts on global health, evidenced by a notable increase in studies addressing mental health and quality of life, fostered by international scientific collaboration. Keyword analysis reveals critical themes, including the pandemic's influence on mental health, physical activity, and social support systems. This research provides valuable insights into the long-term consequences of the pandemic and highlights adaptive strategies for managing future crises. By identifying key trends and research gaps, the study serves as an essential resource for academics, policymakers, and public health practitioners, offering a roadmap for future investigations.</p>","PeriodicalId":46740,"journal":{"name":"Health Care Analysis","volume":" ","pages":"446-478"},"PeriodicalIF":1.6,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142910988","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"哲学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-12-01Epub Date: 2025-09-27DOI: 10.1007/s10728-025-00544-z
Hanna Schroeder, Yitzhak Ben Menachem, Netta Bentur, Dina Cherno, Lior Barak, Ayelet Grinbaum Arizon
Israel's aging population and demographic growth have driven a surge in hospitalizations, prompting the Ministry of Health to expand community-based care. In 2019, a financial incentive was introduced, special payments to health maintenance organizations (HMOs) for Hospital at Home (HaH) services, implemented in 2020. This study examines changes in the volume and geographic distribution of HaH following this policy. We analyzed retrospective Ministry of Health data on all HaH admissions from 2017-2023, excluding COVID-19 cases. Data included length of stay, referral source (hospital vs. community), patient age, and residence. HMOs reported 70,203 HaH admissions during the study period, increasing from only 8 in 2017 to 33,141 in 2023. Growth was most rapid after the payment policy was introduced. The mean monthly HaH days rose sharply, reaching 2762 in 2023. Over time, the proportion of HaH admissions from central Israel increased, while peripheral areas saw a relative decline. Readmission rates to HaH were low-3% within 1 week, and 8%, 15%, and 23% within 1, 3, and 6 months, respectively. HaH could play a significant role in meeting Israel's growing demand for inpatient care. To maximize its impact, policy efforts should address barriers to expansion, particularly in peripheral regions, and promote more equitable geographic access.
{"title":"Hospitalizations at Home in Israel, a Retrospective Observational Study.","authors":"Hanna Schroeder, Yitzhak Ben Menachem, Netta Bentur, Dina Cherno, Lior Barak, Ayelet Grinbaum Arizon","doi":"10.1007/s10728-025-00544-z","DOIUrl":"10.1007/s10728-025-00544-z","url":null,"abstract":"<p><p>Israel's aging population and demographic growth have driven a surge in hospitalizations, prompting the Ministry of Health to expand community-based care. In 2019, a financial incentive was introduced, special payments to health maintenance organizations (HMOs) for Hospital at Home (HaH) services, implemented in 2020. This study examines changes in the volume and geographic distribution of HaH following this policy. We analyzed retrospective Ministry of Health data on all HaH admissions from 2017-2023, excluding COVID-19 cases. Data included length of stay, referral source (hospital vs. community), patient age, and residence. HMOs reported 70,203 HaH admissions during the study period, increasing from only 8 in 2017 to 33,141 in 2023. Growth was most rapid after the payment policy was introduced. The mean monthly HaH days rose sharply, reaching 2762 in 2023. Over time, the proportion of HaH admissions from central Israel increased, while peripheral areas saw a relative decline. Readmission rates to HaH were low-3% within 1 week, and 8%, 15%, and 23% within 1, 3, and 6 months, respectively. HaH could play a significant role in meeting Israel's growing demand for inpatient care. To maximize its impact, policy efforts should address barriers to expansion, particularly in peripheral regions, and promote more equitable geographic access.</p>","PeriodicalId":46740,"journal":{"name":"Health Care Analysis","volume":" ","pages":"401-412"},"PeriodicalIF":1.6,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145179410","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"哲学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-12-01Epub Date: 2025-05-29DOI: 10.1007/s10728-025-00527-0
Heldi Marleen Lang
The diagnosis and perception of autism have undergone significant transformations throughout history. Initially conceptualised as a symptom of schizophrenia, autism later emerged as a distinct diagnosis, evolving into the broader classification of autism spectrum disorder (ASD). This essay explores the main shifts in the understanding of autism throughout its history and different approaches to its treatment. While the traditional psychiatric perspective aligns with a naturalist view of disease, the Neurodiversity Movement advocates for a normative approach, emphasising societal adaptation over medical intervention. The study examines historical milestones, including the contributions of Eugen Bleuler, Grunya Sukhareva, Leo Kanner, and Hans Asperger, alongside the conceptual transition from low- and high-functioning autism to the spectrum model. It also discusses the implications of language in shaping autism discourse, highlighting the shift from person-first to identity-first terminology. The essay ultimately argues that the expansion of the autism diagnosis supports the neurodiversity paradigm, which fosters greater inclusion and empowerment of neurodivergent individuals. However, considerations of severity and linguistic framing remain crucial in advancing this perspective.
{"title":"History of the Autism Diagnosis- How the Perspectives Have Changed.","authors":"Heldi Marleen Lang","doi":"10.1007/s10728-025-00527-0","DOIUrl":"10.1007/s10728-025-00527-0","url":null,"abstract":"<p><p>The diagnosis and perception of autism have undergone significant transformations throughout history. Initially conceptualised as a symptom of schizophrenia, autism later emerged as a distinct diagnosis, evolving into the broader classification of autism spectrum disorder (ASD). This essay explores the main shifts in the understanding of autism throughout its history and different approaches to its treatment. While the traditional psychiatric perspective aligns with a naturalist view of disease, the Neurodiversity Movement advocates for a normative approach, emphasising societal adaptation over medical intervention. The study examines historical milestones, including the contributions of Eugen Bleuler, Grunya Sukhareva, Leo Kanner, and Hans Asperger, alongside the conceptual transition from low- and high-functioning autism to the spectrum model. It also discusses the implications of language in shaping autism discourse, highlighting the shift from person-first to identity-first terminology. The essay ultimately argues that the expansion of the autism diagnosis supports the neurodiversity paradigm, which fosters greater inclusion and empowerment of neurodivergent individuals. However, considerations of severity and linguistic framing remain crucial in advancing this perspective.</p>","PeriodicalId":46740,"journal":{"name":"Health Care Analysis","volume":" ","pages":"337-348"},"PeriodicalIF":1.6,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144175331","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"哲学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-12-01Epub Date: 2025-09-18DOI: 10.1007/s10728-025-00540-3
Lindsay Van Dam, Sheri L Price, Hossein Khalili, John H V Gilbert
The COVID-19 pandemic presented unprecedented challenges for health and social care practice worldwide. Ensuring effective collaboration between health and social care is essential to meet population health needs- especially during crisis. Interprofessional education for collaborative practice (IPECP) during students' pre-licensure education is an important primer for collaboration in practice. Within IPECP, students are provided opportunities to learn about, with, and from each other, lending to professional and interprofessional socialization and processes of developing an interprofessional identity. Few studies have followed health professions graduates longitudinally from pre-licensure into professional practice to understand how IPECP supports new professionals' readiness for collaborative practice. The COVID-19 pandemic coincided with the timing of this longitudinal study of students' experiences of IPECP and collaboration upon entry to practice. This interpretive, narrative analysis provides novel insights to how collaboration was experienced during the pandemic and implications for interprofessional identity development. The participant narratives provide insight into the contexts, settings, and experiences that were critical catalysts for connection and collaboration between professionals. Findings support a need for IPECP throughout pre-licensure and into practice and provides important direction for innovative curricula, policy and practice development to prepare future collaborative practitioners and interprofessional teams.
{"title":"Collaboration During Crisis: New Graduates' Experiences of Interprofessional Practice During the COVID-19 Pandemic.","authors":"Lindsay Van Dam, Sheri L Price, Hossein Khalili, John H V Gilbert","doi":"10.1007/s10728-025-00540-3","DOIUrl":"10.1007/s10728-025-00540-3","url":null,"abstract":"<p><p>The COVID-19 pandemic presented unprecedented challenges for health and social care practice worldwide. Ensuring effective collaboration between health and social care is essential to meet population health needs- especially during crisis. Interprofessional education for collaborative practice (IPECP) during students' pre-licensure education is an important primer for collaboration in practice. Within IPECP, students are provided opportunities to learn about, with, and from each other, lending to professional and interprofessional socialization and processes of developing an interprofessional identity. Few studies have followed health professions graduates longitudinally from pre-licensure into professional practice to understand how IPECP supports new professionals' readiness for collaborative practice. The COVID-19 pandemic coincided with the timing of this longitudinal study of students' experiences of IPECP and collaboration upon entry to practice. This interpretive, narrative analysis provides novel insights to how collaboration was experienced during the pandemic and implications for interprofessional identity development. The participant narratives provide insight into the contexts, settings, and experiences that were critical catalysts for connection and collaboration between professionals. Findings support a need for IPECP throughout pre-licensure and into practice and provides important direction for innovative curricula, policy and practice development to prepare future collaborative practitioners and interprofessional teams.</p>","PeriodicalId":46740,"journal":{"name":"Health Care Analysis","volume":" ","pages":"349-367"},"PeriodicalIF":1.6,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145082003","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"哲学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-12-01Epub Date: 2025-03-06DOI: 10.1007/s10728-025-00514-5
Zhenwei You, Yahui Wang, Yineng Xiao
In recent years, artificial intelligence (AI) has become more important in healthcare. It has the ability to completely change how patients are diagnosed, treated, and cared for. To make sure AI is properly supervised in healthcare, many problems need to be solved. This calls for a broad approach that includes policy, technology, and involving important people. This study investigates the governance of AI within healthcare, highlighting the importance of policy, technology, and stakeholder engagement. Adopting a mixed-methods research design, the study encompasses surveys, interviews, and document analysis to comprehensively explore diverse perspectives on AI governance. Purposive sampling techniques were employed to gather 897 valid samples, ensuring diversity across stakeholder groups. Surveys gathered quantitative data on demographic characteristics and attitudes toward AI governance, while interviews provided deeper insights into stakeholders' experiences and recommendations. Document analysis supplemented data collection by reviewing policy documents, guidelines, and academic literature related to AI governance. This study merges quantitative and qualitative data to thoroughly investigate AI governance, enabling the identification of policy implications and actionable recommendations. This study contributes novel insights by adopting a comprehensive approach to AI governance in healthcare, integrating policy, technology, and stakeholder engagement perspectives. Unlike previous studies focusing solely on individual aspects of AI governance, this research provides a holistic understanding of the complex dynamics involved. This research offers important insights into AI governance by investigating the impact of stakeholder engagement, ethical considerations, digital health disparities, governance structures, and health communication strategies on AI integration in healthcare, ultimately aiding in policy development and implementation.
{"title":"Analysing the Suitability of Artificial Intelligence in Healthcare and the Role of AI Governance.","authors":"Zhenwei You, Yahui Wang, Yineng Xiao","doi":"10.1007/s10728-025-00514-5","DOIUrl":"10.1007/s10728-025-00514-5","url":null,"abstract":"<p><p>In recent years, artificial intelligence (AI) has become more important in healthcare. It has the ability to completely change how patients are diagnosed, treated, and cared for. To make sure AI is properly supervised in healthcare, many problems need to be solved. This calls for a broad approach that includes policy, technology, and involving important people. This study investigates the governance of AI within healthcare, highlighting the importance of policy, technology, and stakeholder engagement. Adopting a mixed-methods research design, the study encompasses surveys, interviews, and document analysis to comprehensively explore diverse perspectives on AI governance. Purposive sampling techniques were employed to gather 897 valid samples, ensuring diversity across stakeholder groups. Surveys gathered quantitative data on demographic characteristics and attitudes toward AI governance, while interviews provided deeper insights into stakeholders' experiences and recommendations. Document analysis supplemented data collection by reviewing policy documents, guidelines, and academic literature related to AI governance. This study merges quantitative and qualitative data to thoroughly investigate AI governance, enabling the identification of policy implications and actionable recommendations. This study contributes novel insights by adopting a comprehensive approach to AI governance in healthcare, integrating policy, technology, and stakeholder engagement perspectives. Unlike previous studies focusing solely on individual aspects of AI governance, this research provides a holistic understanding of the complex dynamics involved. This research offers important insights into AI governance by investigating the impact of stakeholder engagement, ethical considerations, digital health disparities, governance structures, and health communication strategies on AI integration in healthcare, ultimately aiding in policy development and implementation.</p>","PeriodicalId":46740,"journal":{"name":"Health Care Analysis","volume":" ","pages":"413-445"},"PeriodicalIF":1.6,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143568197","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"哲学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-12-01Epub Date: 2025-05-28DOI: 10.1007/s10728-025-00523-4
Junjian Zheng, Hao Hong, Nan Wang, JiuJian Sun, Xiaowei Xu
Recently, the most critical psychological challenges have compelled healthcare professionals to confront their mental health issues. Consequently, many employees experiencing elevated levels of psychological stress have reported disengagement and dissatisfaction across various aspects of their work. Given the strong association between individual well-being and job satisfaction, how healthcare employees regulate their emotions and psychological health to attain job satisfaction remains largely unexplored. To address this issue, the present study investigates the effects of mindfulness, emotional intelligence, and employee well-being on healthcare workers' emotional and mental health while considering the mediating role of employee satisfaction and the moderating role of digital leadership. Data were collected through a structured questionnaire distributed to 633 healthcare employees in China. We employed SPSS and Smart PLS for reliability, discriminant validity, and structural equation modeling analyses. The findings reveal that mindfulness (MFN), emotional intelligence (EI), and employee well-being (EWB) significantly and positively influence both emotional health (EH) and mental health (MH). Furthermore, employee satisfaction (ES) mediated the relationship between mindfulness, emotional intelligence, and employee well-being to emotional and mental health. The moderating role of digital leadership (DL) was also examined, demonstrating its influence on emotional and mental health. These findings hold important implications for healthcare professionals, managers, policymakers, practitioners, and other stakeholders seeking to enhance employee well-being and job satisfaction in healthcare settings.
{"title":"Impact of Mindfulness, Emotional Intelligence, and Employee Well-being on Mental Healthcare of Workers' Affectiveness: The Mediating Role of Employee Satisfaction and the Moderating Effect of Digital Leadership.","authors":"Junjian Zheng, Hao Hong, Nan Wang, JiuJian Sun, Xiaowei Xu","doi":"10.1007/s10728-025-00523-4","DOIUrl":"10.1007/s10728-025-00523-4","url":null,"abstract":"<p><p>Recently, the most critical psychological challenges have compelled healthcare professionals to confront their mental health issues. Consequently, many employees experiencing elevated levels of psychological stress have reported disengagement and dissatisfaction across various aspects of their work. Given the strong association between individual well-being and job satisfaction, how healthcare employees regulate their emotions and psychological health to attain job satisfaction remains largely unexplored. To address this issue, the present study investigates the effects of mindfulness, emotional intelligence, and employee well-being on healthcare workers' emotional and mental health while considering the mediating role of employee satisfaction and the moderating role of digital leadership. Data were collected through a structured questionnaire distributed to 633 healthcare employees in China. We employed SPSS and Smart PLS for reliability, discriminant validity, and structural equation modeling analyses. The findings reveal that mindfulness (MFN), emotional intelligence (EI), and employee well-being (EWB) significantly and positively influence both emotional health (EH) and mental health (MH). Furthermore, employee satisfaction (ES) mediated the relationship between mindfulness, emotional intelligence, and employee well-being to emotional and mental health. The moderating role of digital leadership (DL) was also examined, demonstrating its influence on emotional and mental health. These findings hold important implications for healthcare professionals, managers, policymakers, practitioners, and other stakeholders seeking to enhance employee well-being and job satisfaction in healthcare settings.</p>","PeriodicalId":46740,"journal":{"name":"Health Care Analysis","volume":" ","pages":"368-400"},"PeriodicalIF":1.6,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144162830","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"哲学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-12-01Epub Date: 2025-10-10DOI: 10.1007/s10728-025-00541-2
Nicola Glover-Thomas
This article examines the complex interplay of cultural practices, genetic health risks, and evolving legal frameworks surrounding consanguineous marriage, with a focus on England and Wales. Consanguineous unions, increase offspring's risk of autosomal recessive genetic disorders and congenital anomalies due to heightened homozygosity. The 'Born in Bradford' study revealed that 37% of babies in the cohort were born to related parents, with over 60% of marriages in the Pakistani-origin population being consanguineous. This was associated with a near doubling of the congenital anomaly risk (3% to 6%) and accounted for an estimated 30% of all congenital anomalies and 25% of infant mortality in Bradford. While Norway and Sweden have recently banned or are set to ban first-cousin marriages, citing public health and forced marriage concerns, England and Wales maintain a permissive stance. Proposed legislation, like the Marriage (Prohibited Degrees of Relationship) Bill 2025, aims to prohibit these unions and is argued to mitigate NHS strain. However, such proposals face significant human rights challenges (right to marry, privacy, non-discrimination) and concerns about driving the practice underground. The paper concludes by advocating for nuanced, culturally sensitive public health strategies-including enhanced genetic counselling, targeted education, and proactive screening-to empower informed choice and improve health outcomes without legal coercion, aiming to balance state responsibility with individual and cultural freedoms.
{"title":"Consanguineous Marriage: Law and Public Health.","authors":"Nicola Glover-Thomas","doi":"10.1007/s10728-025-00541-2","DOIUrl":"10.1007/s10728-025-00541-2","url":null,"abstract":"<p><p>This article examines the complex interplay of cultural practices, genetic health risks, and evolving legal frameworks surrounding consanguineous marriage, with a focus on England and Wales. Consanguineous unions, increase offspring's risk of autosomal recessive genetic disorders and congenital anomalies due to heightened homozygosity. The 'Born in Bradford' study revealed that 37% of babies in the cohort were born to related parents, with over 60% of marriages in the Pakistani-origin population being consanguineous. This was associated with a near doubling of the congenital anomaly risk (3% to 6%) and accounted for an estimated 30% of all congenital anomalies and 25% of infant mortality in Bradford. While Norway and Sweden have recently banned or are set to ban first-cousin marriages, citing public health and forced marriage concerns, England and Wales maintain a permissive stance. Proposed legislation, like the Marriage (Prohibited Degrees of Relationship) Bill 2025, aims to prohibit these unions and is argued to mitigate NHS strain. However, such proposals face significant human rights challenges (right to marry, privacy, non-discrimination) and concerns about driving the practice underground. The paper concludes by advocating for nuanced, culturally sensitive public health strategies-including enhanced genetic counselling, targeted education, and proactive screening-to empower informed choice and improve health outcomes without legal coercion, aiming to balance state responsibility with individual and cultural freedoms.</p>","PeriodicalId":46740,"journal":{"name":"Health Care Analysis","volume":" ","pages":"321-336"},"PeriodicalIF":1.6,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12634778/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145276201","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"哲学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-11-27DOI: 10.1007/s10728-025-00550-1
Alicia Hall
Health care price transparency tools have proliferated across the United States in recent years. While these tools are primarily intended to help control rising healthcare costs, they are also frequently described as empowering patients by providing the financial information needed to make more fully informed decisions about medical care. If these tools do empower patients, then the money and time invested in developing and maintaining them could plausibly be justified even if price transparency proves largely ineffective at cost-containment. Using Nancy Kass's public health ethics framework, I explore whether price transparency can rightly be seen as achieving the aim of empowering patients. In examining this issue, I distinguish between what I call passive price transparency initiatives (where the information is made available for patients to find, should they choose to look for it) from active price transparency initiatives (where information about costs is given directly to patients). Most existing price transparency initiatives are passive, and I argue that these programs, rather than empowering patients, instead risk increasing patient burdens in a way that is most significant for those who are already worse off. Only active price transparency (in other words, price disclosure) can be seen as empowering patients in a fair and not overly burdensome way.
{"title":"Price Transparency and Patient Empowerment.","authors":"Alicia Hall","doi":"10.1007/s10728-025-00550-1","DOIUrl":"https://doi.org/10.1007/s10728-025-00550-1","url":null,"abstract":"<p><p>Health care price transparency tools have proliferated across the United States in recent years. While these tools are primarily intended to help control rising healthcare costs, they are also frequently described as empowering patients by providing the financial information needed to make more fully informed decisions about medical care. If these tools do empower patients, then the money and time invested in developing and maintaining them could plausibly be justified even if price transparency proves largely ineffective at cost-containment. Using Nancy Kass's public health ethics framework, I explore whether price transparency can rightly be seen as achieving the aim of empowering patients. In examining this issue, I distinguish between what I call passive price transparency initiatives (where the information is made available for patients to find, should they choose to look for it) from active price transparency initiatives (where information about costs is given directly to patients). Most existing price transparency initiatives are passive, and I argue that these programs, rather than empowering patients, instead risk increasing patient burdens in a way that is most significant for those who are already worse off. Only active price transparency (in other words, price disclosure) can be seen as empowering patients in a fair and not overly burdensome way.</p>","PeriodicalId":46740,"journal":{"name":"Health Care Analysis","volume":" ","pages":""},"PeriodicalIF":1.6,"publicationDate":"2025-11-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145641337","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"哲学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}